We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio

News   Jan 07, 2014

 
Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio
 
 
 

RELATED ARTICLES

Immunological Insight Offer Improvements in Salmonella Vaccines

News

A breakthrough in understanding which cells afford optimal protection against Salmonella infection is a critical step in developing a more effective and safe vaccine.

READ MORE

Gene Therapy Eliminates Mutant Mitochondria DNA in Mouse Heart

News

Using gene therapy, researchers have eliminated damaged DNA in mitochondrial diseases, in a mouse model.

READ MORE

Influenza Virus Molecules Set Immune Response Into Overdrive

News

Mini viral RNA plays a key role in the immune response that is triggered by influenza infections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE